A new study, co-conducted by Binghamton University Assistant Professor of Biomedical Engineering Amber Doiron, is one of the first of its kind to look deeper into these nanoparticles in regards to health. Credit: Binghamton University, State University of New York
Millions of Americans suffer from neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Researchers have identified new treatments, such as cerebrolysin, which are promising, but present clinical approaches are ineffective as critical concentrations of the drug dissipate within the body prior to reaching the central nervous system and brain.
Even with pre-operative imaging methods, surgeons still depend on visual inspection in order to located malignant tissues during surgery.
In certain patients, castrate-resistant or metastatic prostate cancer can spread to the bone. Although many new treatments are available, they can have a hard time reaching the bone and frequently result in missing the metastatic lesions.
As part of an innovative research, scientists from MIT have created nanoparticles with the ability to deliver the CRISPR genome-editing system for particularly modifying the genes in mice. The researchers used the nanoparticles to deliver the CRISPR components, thereby avoiding the necessity of using viruses for carrying the components.
Polymer nanoagents capable of ‘lighting up’ small areas of diseased tissues that standard methods fail to detect, have been developed by a research team headed by Nanyang Technological University, Singapore (NTU Singapore).
While the simplest definition of a “theranostic” nanoparticle is a nanoparticle that merely has a therapeutic moiety and imaging or diagnostic moiety on the same particle, the authors of a review article published in SLAS Technology pay more attention to and highlight the platforms where disease monitoring and self-reporting is possible in real-time because of the synergistic nature of the components present on the theranostic particles.
A recent study reveals that a 70-year-old malaria drug is capable of blocking immune cells in the liver allowing the arrival of nanoparticles at their intended tumor site, thus overcoming a major obstacle of targeted drug delivery, according to a team of researchers headed by Houston Methodist.
An innovative laser system that can be used to shape nanometric gold particles, measuring one-millionths of a millimeter, to enhance their characteristics in photonics and biomedicine has been developed through a research conducted at the Universidad Complutense de Madrid (UCM). The study has now been reported in the Science journal.
ITMO University researchers have developed a new approach for attaining non-toxic magnetic photonic crystals, increasing their applications from chiefly photonics to biomedicine.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.